International Patent: SUSTAINED-RELEASE FORMULATION COMPRISING METFORMIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND METHOD FOR PREPARING SAME

GENEVA, July 1 -- DAEWOONG THERAPEUTICS INC. filed a patent application (KR2025/016296) for “SUSTAINED-RELEASE FORMULATION COMPRISING METFORMIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, AND METHOD FOR PREPARING SAME”. With publication no. WO/2026/127322, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/20

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....